Concanavalin a affinity chromatography for efficient baculovirus purification

Biotechnology Progress

Volumn 25, Issue 6, 2009, Pages 1669-1677

  Chen, Guan Yu ^a   Chen, Chi Yuan ^a   Chang, Margaret Dah Tsyr ^a   Matsuura, Yoshiharu ^b,c   Hu, Yu Chen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Baculovirus; Chromatography; Con A; Gene therapy; Purification; Virus vector

Indexed keywords

AFFINITY INTERACTIONS; BACULOVIRUS; CON A; CONCANAVALIN A; CUMULATIVE RECOVERY; DIAFILTRATION; ENVELOPE PROTEINS; FLOWTHROUGH; GENE DELIVERY; HIGH QUALITY; IN-VIVO; PURIFICATION PROCESS; ROOM TEMPERATURE; SURFACE GLYCOPROTEINS; TANGENTIAL FLOW; TRANSDUCING; VACCINE VECTORS; VIRAL PARTICLES;

AFFINITY CHROMATOGRAPHY; CHROMATOGRAPHIC ANALYSIS; GENE THERAPY; GENE TRANSFER; GLYCOPROTEINS; MICROFILTRATION; PROTEINS; RECOVERY; SYSTEM STABILITY; VIRUSES;

PURIFICATION;

CONCANAVALIN A; METHYL MANNOSIDE; METHYLMANNOSIDE; SODIUM CHLORIDE; TROMETAMOL;

AFFINITY CHROMATOGRAPHY; ARTICLE; BACULOVIRUS; CHEMISTRY; DIALYSIS; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOLECULAR WEIGHT; PH; TRANSMISSION ELECTRON MICROSCOPY;

BACULOVIRIDAE; CHROMATOGRAPHY, AFFINITY; CONCANAVALIN A; DIALYSIS; HYDROGEN-ION CONCENTRATION; METHYLMANNOSIDES; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR WEIGHT; SODIUM CHLORIDE; TROMETHAMINE;

EID: 73249139796     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1002/btpr.253     Document Type: Article

References (50)

1. Kost TA, Condreay JP, Jarvis DL. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol. 2005;23:567-575.
2. Hu Y-C. Baculoviral vectors for gene delivery: a review. Curr Gene Ther. 2008;8:54-65.
3. Tani H, Abe T, Matsunaga TM, Moiihi K, Matsuura Y. Baculovirus vector for gene delivery and vaccine development. Future Virol. 2008;3:35-43.
4. Kaikkonen MU, Raty JK, Airenne KJ, Wirth T, Heikura T, Yla-Herttuala S. Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo. Gene Ther. 2006;13:304-312.
5. Makela AR, Oker-Blom C. Baculovirus display: a multifunctional technology for gene delivery and eukaryotic library development. Adv Virus Res. 2006;68:91-112.
6. Condreay JP, Ames RS, Hassan NJ, Kost TA, Merrihew RV, Mossakowska DE, Pountney DJ, Romanos MA. Baculoviruses and mammalian cell-based assays for drug screening. Adv Virus Res. 2006;68:255-286.
7. Kost TA, Condreay JP, Ames RS, Rees S, Romanos MA. Implementation of bacmam virus gene delivery technology in a drug discovery setting. Drug Discov Today. 2007;12:396-403.
8. Lesch HP, Turpeinen S, Niskanen EA, Mähonen AJ, Airenne KJ, Ylä-Herttuala S. Generation of lentivirus vectors using recombinant baculoviruses. Gene Ther. 2008;15:1280-1286.
9. Huang K-S, Lo W-H, Chung Y-C, Lai Y-K, Chen C-Y, Chou S-T, Hu Y-C. Combination of baculovirus-mediated gene deliv-ery and packed-bed reactor for scalable production of adeno-associated Virus. Hum Gene Ther. 2007;18:1161-1170.
10. Zeng J, Du J, Zhao Y, Palanisamy N, Wang S. Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem Cells. Stem Cells. 2007;25:1055-1061.
11. Ho Y-C, Lee H-P, Hwang S-M, Lo W-H, Chen H-C, Chung C-K, Hu Y-C. Baculovirus transduction of human mesenchymal stem cell-derived progenitor cells: variation of transgene expression with cellular differentiation states. Gene Ther. 2006;13: 1471-1479.
12. Chen H-C, Sung L-Y, Lo W-H, Chuang C-K, Wang Y-H, Lin J-L, Hu Y-C. Combination of baculovirus-mediated Bmp-2 expression and rotating-shaft bioreactor culture synergistically enhances cartilage formation. Gene Ther. 2008;15:309-317.
13. Chuang C-K, Sung L-Y, Hwang S-M, Lo W-H, Chen H-C, Hu Y-C. Baculovirus as a new gene delivery vector for stem cells engineering and bone tissue engineering. Gene Ther. 2007;14: 1417-1424.
14. Raty JK, Liimatainen T, Huhtala T, Kaikkonen MU, Airenne KJ, Hakumaki JM, Narvanen A, Yla-Herttuala S. Spect/Ct imaging of baculovirus biodistribution in rat. Gene Ther. 2007;14: 930-938.
15. Tani H, Limn CK, Yap CC, Onishi M, Nozaki M, Nishimune Y, Okahashi N, Kitagawa Y, Watanabe R, Mochizuki R, Moriishi K, Matsuura Y. In vitro and in vivo gene delivery by recombinant baculoviruses. J Virol. 2003;77:9799-9808.
16. Wang C-Y, Li F, Yang Y, Guo H-Y, Wu C-X, Wang S. Recombinant baculovirus containing the diphtheria toxin a gene for malignant glioma therapy. Cancer Res. 2006;66:5798-5806.
17. Yang D-G, Chung Y-C, Lai Y-K, Lai C-W, Liu H-J, Hu Y-C. Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. Mol Ther. 2007;15:989-996.
18. van Oers MM. Vaccines for viral and parasitic diseases produced with baculovirus vectors. Adv Virus Res. 2006;68:193-253.
19. Strauss R, Huser A, Ni S, Tuve S, Kiviat N, Sow PS, Hofmann C, Lieber A. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium Falciparum circumsporozoite protein. Mol Ther. 2007;15:193-202.
20. O'Reilly D, Miller L, Luckow V. In Baculovirus Expression Vectors: A Laboratory Manual. New York: W.H. Freeman; 1992:109-215.
21. Barsoum J. Concentration of recombinant baculovirus by cation-exchange chromatography. Biotechniques. 1999;26:834-840.
22. Kalbfuss B, Wolff M, Morenweiser R, Reichl U. Purification of cell culture-derived human influenza a virus by size-exclusion and anion-exchange chromatography. Biotechnol Bioeng. 2007;96: 932-944.
23. Chahal PS, Aucoin MG, Kamen A. Primary recovery and chromatographic purification of adeno-associated virus type 2 produced by baculovirus/insect cell system. J Virol Methods. 2007;139:61-70.
24. Rodrigues T, Carvalho A, Carmo M, Carrondo MJT, Alves PM, Cruz PE. Scaleable purification process for gene therapy retroviral vectors. J Gene Med. 2007;9:233-243.
25. Segura MM, Garnier A, Durocher Y, Coelho H, Kamen A. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification. Biotechnol Bioeng. 2007;98:789-799.
26. Arnold GS, Sasser AK, Stachler MD, Bartlett JS. Metabolic biotinylation provides a unique platform for the purification and targeting of multiple Aav vector serotypes. Mol Ther. 2006;14: 97-106.
27. Koerber JT, Jang JH, Yu JH, Kane RS, Schaffer DV. Engineering adeno-associated virus for one-step purification via immobilized metal affinity chromatography. Hum Gene Ther. 2007;18: 367-378.
28. Hu Y-C, Tsai C-T, Chung Y-C, Lu J-T, Hsu JT-A. Generation of chimeric baculovirus with histidine-tags displayed on the envelope and its purification using immobilized metal affinity chromatography. Enzyme Microb Technol. 2003;33:445-452.
29. Kaikkonen MU, Viholainen JI, Narvanen A, Yla-Herttuala S, Airenne KJ. Targeting and purification of metabolically biotinylated baculovirus. Hum Gene Ther. 2008;19:589-600.
30. Transfiguracion J, Jorio H, Meghrous J, Jacob D, Kamen A. High yield purification of functional baculovirus vectors by size exclusion chromatography. J Virol Methods. 2007;142:21-28.
31. Wu C, Soh KY, Wang S. Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant baculovirus and baculovirus Gp64 protein. Hum Gene Ther. 2007;18:665-672.
32. Andujar-Sanchez M, Camara-Artigas A, Jara-Perez V. Purification of angiotensin I converting enzyme from pig lung using concanavalin-A sepharose chromatography. J Chromatogr B. 2003;783:247-252.
33. Franco Fraguas L, Batista-Viera F, Carlsson J. Preparation of high-density concanavalin A adsorbent and its use for rapid, high-yield purification of peroxidase from horseradish roots. J Chromatogr B. 2004;803:237-241.
34. Ray PK, Raychaudhuri S. Differential binding affinity of immobilized concanavalin A sepharose 4b for normal and myelomatous immunoglobulins. Biomed Pharmacother. 1982;36:206-210.
35. Tani H, Limn CK, Yap CC, Onishi M, Nozaki M, Nishimune Y, Okahashi N, Kitagawa Y, Watanabe R, Mochizuki R, Moriishi K, Matsuura Y. In vitro and in vivo gene delivery by recombinant baculoviruses. J Virol. 2003;77:9799-9808.
36. Matsuo E, Tani H, Lim C, Komoda Y, Okamoto T, Miyamoto H, Moriishi K, Yagi S, Patel AH, Miyamura T, Matsuura Y. Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus. Biochem Biophys Res Commun. 2006;340:200-208.
37. Chan Z-R, Lai C-W, Lee H-P, Chen H-C, Hu Y-C. Determination of the baculovirus transducing titer in mammalian cells. Biotechnol Bioeng. 2006;93:564-571.
38. Tsai C-T, Chan Z-R, Lu J-T, Yang D-G, Lo W-H, Hu Y-C. Factors influencing the production and storage of baculovirus for gene delivery: an alternative perspective from the transducing titer assay. Enzyme Microb Technol. 2007;40:1345-1351.
39. Shen CF, Meghrous J, Kamen A. Quantitation of baculovirus particles by flow cytometry. J Virol Methods. 2002;105:321-330.
40. Kasman LM, Volkman LE. Filamentous actin is required for lepidopteran nucleopolyhedrovirus progeny production. J Gen Virol. 2000;81:1881-1888.
41. Wu E, Trauger SA, Pache L, Mullen TM, von Seggern DJ, Siuzdak G, Nemerow GR. Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J Virol. 2004;78:3897-3905.
42. Green AP, Huang JJ, Scott MO, Kierstead TD, Beaupre I, Gao G-P, Wilson JM. A new scalable method for the purification of recombinant adenovirus vectors. Hum Gene Ther. 2002;13: 1921-1934.
43. Ozuer A, Wechuck JB, Russell B, Wolfe D, Goins WF, Glorioso JC, Ataai MM. Evaluation of infection parameters in the production of replication-defective Hsv-1 viral vectors. Biotechnol Prog. 2002;18:476-482.
44. Coroadinha AS, Silva AC, Pires E, Coelho A, Alves PM, Carrondo MJ. Effect of osmotic pressure on the production of retroviral vectors: enhancement in vector stability. Biotechnol Bioeng. 2006;94:322-329.
45. Segura MM, Kamen A, Trudel P, Garnier A. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography. Biotechnol Bioeng. 2005;90:391-404.
46. Jorio H, Tran R, Meghrous J, Bourget L, Kamen A. Analysis of baculovirus aggregates using flow cytometry. J Virol Methods. 2006;134:8-14.
47. Wickramasinghe SR, Kalbfuss B, Zimmermann A, Thom V, Reichl U. Tangential flow microfiltration and ultrafiltration for human influenza a virus concentration and purification. Biotechnol Bioeng. 2005;92:199-208.
48. Geraerts M, Michiels M, Baekelandt V, Debyser Z, Gijsbers R. Upscaling of lentiviral vector production by tangential flow filtration. J Gene Med. 2005;7:1299-1310.
49. Grzenia DL, Carlson JO, Czermak P, Han B, Specht RK, Wickramasinghe SR. Purification of densonucleosis virus by tangential flow ultrafiltration. Biotechnol Prog. 2006;22:1346-1353.
50. Kuiper M, Sanches RM, Walford JA, Slater NKH. Purification of a functional gene therapy vector derived from moloney murine leukaemia virus using membrane filtration and ceramic hydroxyapatite chromatography. Biotechnol Bioeng. 2002;80:445-453.